Oral vaccination against Helicobacter pylori infection is not effective in mice with fas ligand deficiency

Digestive Diseases and Sciences

Volumn 50, Issue 12, 2005, Pages 2300-2306

  Avitzur, Yaron ^a   Galindo Mata, Esther ^a   Jones, Nicola L ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apoptosis; Cytokine; gld mice; Helicobacter pylori; T helper; Vaccination

Indexed keywords

CHOLERA TOXIN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RESPONSE; DRUG TREATMENT FAILURE; EFFECTOR CELL; FEMALE; HELICOBACTER INFECTION; INFECTION PREVENTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; APOPTOSIS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERLEUKINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TUMOR NECROSIS FACTORS; VACCINATION;

EID: 30844447235     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3051-5     Document Type: Article

References (36)

1. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 347:1175-1186, 2002
2. Shirin H, Moss SF: Helicobacter pylori induced apoptosis. Gut 43:592-594, 1998
3. Goh KL: Update on the management of Helicobacter pylori infection, including drug-resistant organisms. J Gastroenterol Hepatol 17:482-487, 2002
4. Lembo A, Caradonna L, Magrone T, et al.: Helicobacter pylori infection, immune response and vaccination. Curr Drug Targets Immune Endocr Metabol Disord 1:199-208, 2001
5. Kusters JG: Recent developments in Helicobacter pylori vaccination. Scand J Gastroenterol Suppl:15-21, 2001
6. Ruggiero P, Peppoloni S, Rappuoli R, Del Giudice G: The quest for a vaccine against Helicobacter pylori: How to move from mouse to man? Microbes Infect 5:749-756, 2003
7. Saldinger PF, Porta N, Launois P, et al.: Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 115:891-897, 1998
8. Hatzifoti C, Wren BW, Morrow WJ: Helicobacter pylori vaccine strategies - triggering a gut reaction. Immunol Today 21:615-619, 2000
9. Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ: Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 71:3628-633, 2003
10. Akhiani AA, Pappo J, Kabok Z, et al.: Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 169:6977-6984, 2002
11. Akhiani AA, Schon K, Lycke N: Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol 173:3348-3356, 2004
12. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 281:1305-1308, 1998
13. Wajant H: The Fas signaling pathway: More than a paradigm. Science 296:1635-1636, 2002
14. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39-13, 1995
15. Matiba B, Mariani SM, Krammer PH: The CD95 system and the death of a lymphocyte. Semin Immunol 9:59-68, 1997
16. Takahashi T, Tanaka M, Brannan CI, et al.: Generalized lympho-proliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
17. Houghton JM, Bloch LM, Goldstein M, Von Hagen S, Korah RM: In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J Infect Dis 182:856-864, 2000
18. Jones NL, Day AS, Jennings H, Shannon PT, Galindo-Mata E, Sherman PM: Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect Immun 70:2591-2597, 2002
19. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 112:1386-1397, 1997
20. Jones NL, Day AS, Jennings HA, Sherman PM: Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 67:4237-4242, 1999
21. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM: Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 151:1695-1703, 1997
22. Sutton P, Danon SJ, Walker M, et al.: Post-immunisation gastritis and Helicobacter infection in the mouse: A long term study. Gut 49:467-473, 2001
23. Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB: Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol 167:926-934, 2001
24. Eaton KA, Krakowka S: Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterology 103:1580-1586, 1992
25. Raghavan S, Svennerholm AM, Holmgren J: Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect Immun 70:4621-4627, 2002
26. Garhart CA, Redline RW, Nedrud JG, Czinn SJ: Clearance of Helicobacter pylori Infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 70:3529-3538, 2002
27. Menaker RJ, Jones NL: Fascination with bacteria-triggered cell death: The significance of Fas-mediated apoptosis during bacterial infection in vivo. Microbes Infect 5:1149-1158, 2003
28. Kohda K, Tanaka K, Aiba Y, Yasuda M, Miwa T, Koga Y: Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. Gut 44:456-462, 1999
29. Scotiniotis IA, Rokkas T, Furth EE, Rigas B, Shiff SJ: Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: Implications for gastric carcinogenesis. Int J Cancer 85:192-200, 2000
30. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ: Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:1848-1857, 1997
31. Cohen PL, Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269, 1991
32. Giese T, Davidson WF: Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 152:2000-2010, 1994
33. Giese T, Davidson WF: The accumulation of B220+ CD4- CD8-(DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells. Int Immunol 7:1213-1223, 1995
34. Giese T, Davidson WF: In CD8+ T cell-deficient lpr/lpr mice, CD4+ B220+ and CD4+ B220-T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol 154:4986-4995, 1995
35. Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L: The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 196:261-267, 2002
36. Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E, Schneck JP: B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J Immunol 171:2421-2426, 2003